Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
27/07/2026 22:24
BRIEF-Sellas Life Sciences Group - Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing July 27 (Reuters) - Sellas Life Sciences Group Inc SLS.O:
SELLAS LIFE SCIENCES GROUP - ARBITRATOR DISMISSES COMPANY'S CLAIMS IN ARBITRATION AGAINST 3D MEDICINES ON JULY 24, 2026 - SEC FILING
SELLAS LIFE SCIENCES GROUP - COMPANY TO PAY ABOUT $1 MILLION OF 3D MEDICINES' LEGAL FEES - SEC FILING
SELLAS LIFE SCIENCES GROUP INC: 3D MEDICINES WILL CONTINUE DEVELOPMENT & COMMERCIALIZATION OF GALINPEPIMUT-S IN GREATER CHINA TERRITORY
Source text: [ID:n0001104659-26-087110]
Further company coverage: SLS.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses